Exagen Inc. Reports Third Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
BTIG Reiterates Buy Rating on Exagen (XGN)
November 12, 2024 4:06 PM ESTBTIG analyst Mark Massaro reiterated a Buy rating and $5.00 price target on Exagen (NASDAQ: XGN).
The analyst comments "Shares of XGN are off 9% today following the company's Q3 results, where they delivered an in-line quarter on an adjusted basis, but came in a little light on a reported basis - the... More
